The Prognostic Role of Interim [18F]FDG PET/CT in Diffuse Large B-Cell Lymphoma: An Updated Systematic Review and Meta-analysis.
The prognostic value of interim 18F-fluorodeoxyglucose positron emission tomography/computed tomography (iPET/CT) in diffuse large B-cell lymphoma (DLBCL) remains a subject of debate due to inconsistencies in timing and interpretation. Scans performed after 4 cycles (iPET4, HR: 3.20) showed slightly stronger prognostic performance than those after 2 cycles (iPET2, HR: 2.84).
The prognostic value of interim 18F-fluorodeoxyglucose positron emission tomography/computed tomography (iPET/CT) in diffuse large B-cell lymphoma (DLBCL) remains a subject of debate due to inconsistencies in timing and interpretation. Scans performed after 4 cycles (iPET4, HR: 3.20) showed slightly stronger prognostic performance than those after 2 cycles (iPET2, HR: 2.84).
What the study was
- Study design
- Meta-analysis
- Sample size
- 335
- Category
- Treatment Innovation
- Maturity
- Potentially Practice-Changing
- Journal
- Clinical lymphoma, myeloma & leukemia
Why it surfaced
Relevant Hematologic malignancies study (promising preliminary signal) meets standard-priority threshold.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.